You do not have permission to edit this page, for the following reasons:

This IP address has been blocked from editing Wikipedia.
This does not affect your ability to read Wikipedia pages.
Most people who see this message have done nothing wrong. Some kinds of blocks restrict editing from specific service providers or telecom companies in response to recent abuse or vandalism, and can sometimes affect other users who are unrelated to that abuse. Review the information below for assistance if you do not believe that you have done anything wrong.

The IP address or range 44.199.0.0/16 has been blocked (disabled) by ‪Blablubbs‬ for the following reason(s):

The IP address that you are currently using has been blocked because it is believed to be a web host provider or colocation provider. To prevent abuse, web hosts and colocation providers may be blocked from editing Wikipedia.
You will not be able to edit Wikipedia using a web host or colocation provider because it hides your IP address, much like a proxy or VPN.
We recommend that you attempt to use another connection to edit. For example, if you use a proxy or VPN to connect to the internet, turn it off when editing Wikipedia. If you edit using a mobile connection, try using a Wi-Fi connection, and vice versa. If you are using a corporate internet connection, switch to a different Wi-Fi network. If you have a Wikipedia account, please log in.
If you do not have any other way to edit Wikipedia, you will need to request an IP block exemption.

How to appeal if you are confident that your connection does not use a colocation provider's IP address:
If you are confident that you are not using a web host, you may appeal this block by adding the following text on your talk page: ((unblock|reason=Caught by a colocation web host block but this host or IP is not a web host. My IP address is _______. Place any further information here. ~~~~)). You must fill in the blank with your IP address for this block to be investigated. Your IP address can be determined here. Alternatively, if you wish to keep your IP address private you can use the unblock ticket request system. There are several reasons you might be editing using the IP address of a web host or colocation provider (such as if you are using VPN software or a business network); please use this method of appeal only if you think your IP address is in fact not a web host or colocation provider.

Administrators: The IP block exemption user right should only be applied to allow users to edit using web host in exceptional circumstances, and requests should usually be directed to the functionaries team via email. If you intend to give the IPBE user right, a CheckUser needs to take a look at the account. This can be requested most easily at SPI Quick Checkuser Requests. Unblocking an IP or IP range with this template is highly discouraged without at least contacting the blocking administrator.

This block will expire on 12:56, 12 May 2024.

Even when blocked, you will usually still be able to edit your user talk page, as well as email administrators and other editors.

For information on how to proceed, please read the FAQ for blocked users and the guideline on block appeals. The guide to appealing blocks may also be helpful.

Other useful links: Blocking policy · Help:I have been blocked
Your IP address is in a range that has been blocked on all Wikimedia Foundation wikis. The block was made by ‪AntiCompositeNumber‬. The reason given is Open proxy/Webhost: Visit the FAQ if you are affected .
- Start of block: 13:55, 18 August 2022
- Expiry of block: 13:55, 18 May 2025
Your current IP address is 44.199.189.47. The blocked range is 44.199.0.0/16. Please include all above details in any queries you make. If you believe you were blocked by mistake, you can find additional information and instructions in the No open proxies global policy. Otherwise, to discuss the block please post a request for review on Meta-Wiki. You could also send an email to the stewards VRT queue at stewards@wikimedia.org including all above details.

You can view and copy the source of this page:

((Use dmy dates|date=March 2018))
((Use British English|date=March 2018))
((primary sources|date=November 2011))
((Infobox company
| name             = Dundee Cell Products Ltd
| logo             = DCPlogo.png
| caption          =
| type             = [[Private company]]
| founded          = 2006
| location         = [[Dundee]], [[Scotland]], UK
| industry         = [[Biotechnology]]
| products         = Biochemical reagents, procedure kits, specialized research products
| services         = Proteomics, DNA cloning, gene synthesis, antibody development, protein expression and purification
| website          = ((URL|http://www.dundeecellproducts.com/))
))
'''Dundee Cell Products''' ('''DCP''') is a biotechnology company headquartered in [[Dundee]], Scotland, United Kingdom.

The company is a bioreagents and life sciences services company which commercialises research tools for [[biochemistry]], [[molecular biology]] and [[cell biology]] research, and provides services in these areas to the life sciences community. The company’s key business activities include research and development of new innovative products and services, commercialization of products in-licensed from academic institutions, distribution of life sciences research products from commercial partners and supply of contract research services to both academic and pharmaceutical/biotechnology companies customers.

== History ==
Dundee Cell Products Ltd was founded in 2006 as a spinout of the internationally renowned School of Life Sciences<ref>((cite web|url=http://www.lifesci.dundee.ac.uk/ |title=School of Life Sciences |publisher=Lifesci.dundee.ac.uk |date= |accessdate=2012-12-27))</ref> of the [[University of Dundee]] by Dr Paul Ajuh [https://www.geminibioscience.com/about-us] (now with [https://www.geminibioscience.com/ Gemini Biosciences] [https://www.geminibioscience.com/]) and Prof. Angus Lamond [http://www.lifesci.dundee.ac.uk/people/angus-lamond (Lamond Lab)]. Since spinout the company has maintained close interactions with researchers at the institution and a strong relationship with the University.

In 2007, the company secured equity investment funding from a syndicate of [[angel investors]] to finance and expand its activities with follow up investment secured in 2009 from angel investors and the Scottish Co-investment Fund (SCF).<ref>((cite web|url=http://www.scottish-enterprise.com/fund-your-business/scottish-investment-bank/scif.aspx |accessdate=16 May 2011 |url-status=dead |archiveurl=https://web.archive.org/web/20110106205706/https://www.scottish-enterprise.com/fund-your-business/scottish-investment-bank/scif.aspx |archivedate=6 January 2011 |title=Scottish Co-investment Fund ))</ref> The investment was secured to support the business’s growth plans. Over the last four years DCP has enjoyed significant growth in its products portfolio and turnover.

== Research and innovation ==
In the past three years, the company has developed and commercialized several new products e.g. SILAC ready to use media and has been involved in proteomics research collaborations with scientists in both academic institutions and pharmaceutical companies.  Some of these projects have been designed to investigate the effects of virus infections on cellular proteomes in order to elucidate the mechanisms and cellular pathways involved in virus–host factor interactions.<ref>Emmott E., Rodgers M.A., Macdonald A., McCrory S., Ajuh P., Hiscox J.A. (2010) Mol. Cell. Proteomics, 9, 1920-1936</ref>  DCP has also collaborated in a [[phosphoproteomics]] project<ref>Wagner W., Ajuh P., Löwer J., Wessler S. (2010) Cell. Commun. Signal. 8, 28</ref> designed to study the molecular mechanisms in the pathogenesis of transmissible spongiform encephalopathies (TSEs) or [[prion]] disease. Transmissible spongiform encephalopathies are fatal diseases associated with the conversion of the cellular prion protein to an abnormal prion protein leading to damage of brain and neural tissue. Examples of prion diseases include [[bovine spongiform encephalopathy]] (BSE, also known as "mad cow disease") in cattle and [[Creutzfeldt–Jakob disease]] (CJD) in humans. There is currently no treatment for prion diseases, which are usually fatal to the host.

Current R&D projects within the company have been focused on developing applications for SILAC quantitative proteomics in predictive toxicology. These projects are designed to provide data that will be used in developing predictive models for drug toxicity early on during the drug discovery and development process.

== Portfolio ==
DCP initially developed [[antibodies]], mammalian cell fractions for precursor mRNA splicing research and tissue culture media specifically formulated for [[SILAC]] quantitative proteomics. The first products commercialized by the company came from the research interests of the founding scientists who saw an opportunity in the market for developing and commercializing high quality research products and services in the research area to other colleagues. The company has subsequently expanded its products and services portfolio into many other areas of life sciences research to better cover the needs of its customers.

=== Product lines ===
Dundee Cell Products commercializes a broad range of life sciences research products (many of which have been developed in-house) including [[cell culture]] media for quantitative proteomics, mammalian cell fractions e.g. nuclei, nucleoli, mitochondria and cell fractions for quantitative proteomics, [[antibodies]], recombinant proteins, fluorescent cell markers and primary mammalian cells. The company’s SILAC ready to use media have been specially formulated to facilitate the use of SILAC technology by non-specialists in proteomics and scientists who are interested in the application of unbiased high throughput quantitative proteomics approaches in their R&D activities.

=== Research services ===
As well as offering research products, the company’s portfolio has grown to include research services designed to accelerate the research activities of scientists in both the academic and biotech/pharmaceutical industry sectors. Some of the research services that DCP offers include [[gene synthesis]], [[DNA cloning]], recombinant protein expression and purification, stable cell line development, custom [[monoclonal]] and [[polyclonal antibody]] development and various proteomics services<ref>((cite web|url=http://www.dundeecellproteomics.com/ |title=Dundee Cell Proteomics |publisher=Dundee Cell Proteomics |date= |accessdate=2012-12-27))</ref> i.e. both quantitative (e.g. SILAQ, [[Tandem Mass Tags]], [[iTRAQ]], [[Isotope-coded affinity tag]] (ICAT), label-free) and qualitative.

In collaboration with scientists at the University of Dundee, the company is developing novel and innovative products and services in the areas of proteomics, molecular biology and cell biology focused on the needs of research scientists in academic institutions as well as those in biotechnology and pharmaceutical companies.

== Corporate information ==
* Mr John Ivinson - Chief Executive Officer
* Professor Angus Lamond -  Scientific Advisor

<ref>[https://www.geminibioscience.com/ Gemini Biosciences Limited]</ref>

== References ==
((reflist))

==External links==
* ((official website|http://www.dundeecellproducts.com/))
((University of Dundee|state=collapsed))
[[Category:Research support companies]]
[[Category:Companies based in Dundee]]
[[Category:Science and technology in Dundee]]

Pages transcluded onto the current version of this page (help):

Dundee Cell Products (edit)
Template:Ambox (view source) (template editor protected)
Template:Cite web (view source) (protected)
Template:Comma separated entries (view source) (template editor protected)
Template:DMCA (view source) (template editor protected)
Template:Dated maintenance category (view source) (template editor protected)
Template:Dated maintenance category (articles) (view source) (template editor protected)
Template:FULLROOTPAGENAME (view source) (template editor protected)
Template:Find sources mainspace (view source) (template editor protected)
Template:Hlist/styles.css (view source) (protected)
Template:Icon (view source) (template editor protected)
Template:Infobox (view source) (template editor protected)
Template:Infobox company (view source) (template editor protected)
Template:Main other (view source) (protected)
Template:Navbox (view source) (template editor protected)
Template:Ns has subpages (view source) (protected)
Template:Official website (view source) (template editor protected)
Template:Primary sources (view source) (template editor protected)
Template:Reflist (view source) (protected)
Template:Reflist/styles.css (view source) (protected)
Template:Template other (view source) (protected)
Template:URL (view source) (template editor protected)
Template:University of Dundee (edit)
Template:Use British English (view source) (template editor protected)
Template:Use dmy dates (view source) (template editor protected)
Module:Arguments (view source) (protected)
Module:Category handler (view source) (protected)
Module:Category handler/blacklist (view source) (protected)
Module:Category handler/config (view source) (protected)
Module:Category handler/data (view source) (protected)
Module:Category handler/shared (view source) (protected)
Module:Check for clobbered parameters (view source) (template editor protected)
Module:Check for unknown parameters (view source) (protected)
Module:Citation/CS1 (view source) (protected)
Module:Citation/CS1/COinS (view source) (protected)
Module:Citation/CS1/Configuration (view source) (protected)
Module:Citation/CS1/Date validation (view source) (protected)
Module:Citation/CS1/Identifiers (view source) (protected)
Module:Citation/CS1/Utilities (view source) (protected)
Module:Citation/CS1/Whitelist (view source) (protected)
Module:Citation/CS1/styles.css (view source) (protected)
Module:Find sources (view source) (template editor protected)
Module:Find sources/config (view source) (template editor protected)
Module:Find sources/links (view source) (template editor protected)
Module:Find sources/templates/Find sources mainspace (view source) (template editor protected)
Module:Icon (view source) (template editor protected)
Module:Icon/data (view source) (template editor protected)
Module:Infobox (view source) (template editor protected)
Module:Infobox/styles.css (view source) (template editor protected)
Module:InfoboxImage (view source) (template editor protected)
Module:Message box (view source) (protected)
Module:Message box/ambox.css (view source) (protected)
Module:Message box/configuration (view source) (protected)
Module:Namespace detect/config (view source) (protected)
Module:Namespace detect/data (view source) (protected)
Module:Navbar (view source) (protected)
Module:Navbar/configuration (view source) (protected)
Module:Navbar/styles.css (view source) (protected)
Module:Navbox (view source) (template editor protected)
Module:Navbox/configuration (view source) (template editor protected)
Module:Navbox/styles.css (view source) (template editor protected)
Module:Ns has subpages (view source) (protected)
Module:Official website (view source) (template editor protected)
Module:Separated entries (view source) (protected)
Module:TableTools (view source) (protected)
Module:URL (view source) (template editor protected)
Module:Unsubst (view source) (protected)
Module:WikidataIB (view source) (template editor protected)
Module:WikidataIB/nolinks (view source) (template editor protected)
Module:WikidataIB/titleformats (view source) (template editor protected)
Module:Yesno (view source) (protected)

Return to Dundee Cell Products.

Retrieved from "https://en.wikipedia.org/wiki/Dundee_Cell_Products"